Trial Profile
A Randomized, Double Blind, Parallel Group, Placebo-controlled Study to Evaluate the Effect of On-demand Treatment With Asimadoline in Patients With Irritable Bowel Syndrome Over 4 Weeks.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 Dec 2009
Price :
$35
*
At a glance
- Drugs Asimadoline (Primary)
- Indications Abdominal pain
- Focus Therapeutic Use
- 19 Aug 2009 New trial record